These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26304873)
1. Management of Germ Cell Cancer: Lessons Learned From a National Database. de Wit R J Clin Oncol; 2015 Oct; 33(28):3078-9. PubMed ID: 26304873 [No Abstract] [Full Text] [Related]
2. Testicular cancer--discoveries and updates. Hanna NH; Einhorn LH N Engl J Med; 2014 Nov; 371(21):2005-16. PubMed ID: 25409373 [No Abstract] [Full Text] [Related]
3. Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979. Rørth M; von der Maase H; Nielsen ES; Schultz H; Pedersen M Prog Clin Biol Res; 1985; 203():539-51. PubMed ID: 3008183 [No Abstract] [Full Text] [Related]
4. State-of-the-art approach in selective curable tumors: germ cell tumors. Rustin G; Rehman F Ann Oncol; 2008 Sep; 19 Suppl 7():vii161-5. PubMed ID: 18790940 [No Abstract] [Full Text] [Related]
5. [Primary testicular tumors in children]. Beresi V; del Pozo H; Quintana J; Latorre JJ; Izzo C Rev Chil Pediatr; 1987; 58(1):69-73. PubMed ID: 2450388 [No Abstract] [Full Text] [Related]
6. Paternity in young patients with testicular cancer--expectations and experience. Aass N; Fosså SD Prog Clin Biol Res; 1988; 269():481-91. PubMed ID: 2839852 [No Abstract] [Full Text] [Related]
11. Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Bosl GJ; Geller NL; Bajorin D Semin Oncol; 1988 Aug; 15(4):339-44. PubMed ID: 2841764 [No Abstract] [Full Text] [Related]
12. Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center. Whitmore WF; Bosl G Acta Urol Belg; 1985; 53(2):341-61. PubMed ID: 2990181 [No Abstract] [Full Text] [Related]
13. Editorial Comment from Dr Beyer to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. Beyer J Int J Urol; 2015 Oct; 22(10):929-30. PubMed ID: 26105542 [No Abstract] [Full Text] [Related]
14. Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. Nakamura T Int J Urol; 2015 Oct; 22(10):928. PubMed ID: 26153458 [No Abstract] [Full Text] [Related]
15. Personal experience in the management of germinal testis tumors. Pizzocaro G Acta Urol Belg; 1985; 53(2):377-93. PubMed ID: 2990183 [No Abstract] [Full Text] [Related]
17. Editorial Comment from Dr O'Carrigan and Dr Grimison to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. O'Carrigan B; Grimison P Int J Urol; 2015 Oct; 22(10):928-9. PubMed ID: 26173657 [No Abstract] [Full Text] [Related]
18. High dose chemotherapy followed by autologous bone marrow re-infusion in relapsing or refractory testicular cancer. Sleijfer DT; Mulder PO; de Vries EG; Koops HS; Willemse PH; Sibinga CT; Mulder NH Prog Clin Biol Res; 1988; 269():429-37. PubMed ID: 2839849 [No Abstract] [Full Text] [Related]
19. The management of germ cell tumors of the testis: an overview. Skinner DG Semin Urol; 1984 Nov; 2(4):189-93. PubMed ID: 6095393 [No Abstract] [Full Text] [Related]
20. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin. Kimura M; Onozawa M; Fujisaki A; Arakawa T; Takeda K; Dalmau J; Hattori K Int J Urol; 2008 Oct; 15(10):942-3. PubMed ID: 19138287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]